This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Apfalter, P. Articles by Hirschl, A. M. Search for Related Content PubMed PubMed Citation Articles by Apfalter, P. Articles by Hirschl, A. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2002, p. 4428-4434, Vol. 40, No. 12
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.12.4428-4434.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Reliability of Nested PCR for Detection of Chlamydia pneumoniae DNA in Atheromas: Results from a Multicenter Study Applying Standardized Protocols

Division of Clinical Microbiology,¹ Division of Hospital Hygiene, Hygiene-Institute,² Department of Occupational and Social Hygiene, Institute of Environmental Health, University of Vienna, Vienna, Austria,⁶ Institute of Respiratory Diseases, University of Milan, IRCCS Policlinico, Milan, Italy,³ Department of Clinical Virology, Umeå University Hospital, Umeå, Sweden,⁴ Department of Medicine, Division of Infectious Diseases, The Johns Hopkins University, Baltimore, Maryland⁵

Received 7 March 2002/ Returned for modification 13 July 2002/ Accepted 12 August 2002

The present multicenter study was designed to find explanations for the discrepancies in the reported rates of detection of Chlamydia pneumoniae DNA in endarterectomy specimens. Coded identical sets of (i) a C. pneumoniae DNA dilution series (panel 1; n = 10), (ii) spiked control tissue specimens (panel 2; n = 10 specimens, including 5 negative controls), and (iii) endarterectomy specimens (panel 3; 15 atheromas, 5 negative controls) were analyzed at four laboratories by three standardized DNA extraction methods in each laboratory and a nested touchdown PCR protocol targeting the ompA gene of C. pneumoniae. Panel 1 samples were correctly identified as positive to levels of 0.3 inclusion-forming units (IFU)/PCR mixture (100%) and 0.03 IFU/PCR mixture (50%). All negative controls were correctly reported as negative. Panel 2 samples were identified as C. pneumoniae positive to levels of 0.01 IFU/PCR mixture (100%) and 0.005 IFU/PCR mixture (91%), independent of the DNA extraction method used, and only one false-positive result was reported. For panel 3 samples, 5 of 240 (2%) analyses (in which DNA extractions and PCR were performed at the same laboratory) were positive; the positive specimens were from three endarterectomy specimens and two negative controls. After exchange of DNA extracts between laboratories, 13 of 15 atheroma samples were C. pneumoniae DNA positive in at least 1 of a series of 48 analyses per atheroma sample; however, the overall positivity rate did not exceed 5% (33 of 720 analyses) and therefore was lower than that for the negative controls (8%; 19 of 240 analyses). Not a single positive result could be achieved when all panel 3 extracts (n = 240 analyses) were reamplified by a 16S rRNA PCR followed by hybridization with a C. pneumoniae-specific probe. Statistical analyses demonstrated that positive results did not occur in an independent and random fashion and could most likely be explained by amplicon carryover at the nested PCR level as well as amplicon introduction during DNA extraction, but not by the patterns of distribution of very low target levels or a certain DNA extraction protocol. The results of studies by nested PCR for detection of the prevalence of C. pneumoniae will always be questionable.

This article has been cited by other articles:

• Diederen, B. M. W., van der Valk, P. D. L. P. M., Kluytmans, J. A. W. J., Peeters, M. F., Hendrix, R. (2007). The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur Respir J 30: 240-244 [Abstract] [Full Text]  
• Cai, H. Y., van Dreumel, T., McEwen, B., Hornby, G., Bell-Rogers, P., McRaild, P., Josephson, G., Maxie, G. (2007). Application and field validation of a PCR assay for the detection of Mycoplasma hyopneumoniae from swine lung tissue samples. jvdi 19: 91-95 [Abstract] [Full Text]  
• Loens, K., Beck, T., Ursi, D., Pattyn, S., Goossens, H., Ieven, M. (2006). Two Quality Control Exercises Involving Nucleic Acid Amplification Methods for Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and Carried Out 2 Years Apart (in 2002 and 2004).. J. Clin. Microbiol. 44: 899-908 [Abstract] [Full Text]  
• Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R. III, Smith, T. F. (2006). Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing. Clin. Microbiol. Rev. 19: 165-256 [Abstract] [Full Text]  
• Apfalter, P., Reischl, U., Hammerschlag, M. R. (2005). In-House Nucleic Acid Amplification Assays in Research: How Much Quality Control Is Needed before One Can Rely upon the Results?. J. Clin. Microbiol. 43: 5835-5841 [Full Text]  
• Littman, A. J., Jackson, L. A., Vaughan, T. L. (2005). Chlamydia pneumoniae and Lung Cancer: Epidemiologic Evidence. Cancer Epidemiol. Biomarkers Prev. 14: 773-778 [Abstract] [Full Text]  
• Berg, H. F., Maraha, B., van der Zee, A., Gielis, S. K., Roholl, P. J. M., Scheffer, G.-J., Peeters, M. F., Kluytmans, J. A. J. W. (2005). Effect of Clarithromycin Treatment on Chlamydia pneumoniae in Vascular Tissue of Patients with Coronary Artery Disease: a Randomized, Double-Blind, Placebo-Controlled Trial. J. Clin. Microbiol. 43: 1325-1329 [Abstract] [Full Text]  
• Pelton, S. I., Hammerschlag, M. R. (2005). Overcoming Current Obstacles in the Management of Bacterial Community-Acquired Pneumonia in Ambulatory Children. CLIN PEDIATR 44: 1-17  
• Maraha, B., Berg, H., Kerver, M., Kranendonk, S., Hamming, J., Kluytmans, J., Peeters, M., van der Zee, A. (2004). Is the Perceived Association between Chlamydia pneumoniae and Vascular Diseases Biased by Methodology?. J. Clin. Microbiol. 42: 3937-3941 [Abstract] [Full Text]  
• Apfalter, P., Barousch, W., Nehr, M., Willinger, B., Rotter, M., Hirschl, A. M. (2004). No Evidence of Involvement of Chlamydia pneumoniae in Severe Cerebrovascular Atherosclerosis by Means of Quantitative Real-Time Polymerase Chain Reaction. Stroke 35: 2024-2028 [Abstract] [Full Text]  
• Ieven, M. M., Hoymans, V. Y., Bosmans, J. M., Sander, D., Winbeck, K., Klingelhofer, J., Etgen, T., Conrad, B. (2004). Early Carotid Atherosclerosis and Chlamydia pneumoniae Seropositivity: Are There Arguments to Treat With Antibiotics? * Response. Circulation 110: e74-e75 [Full Text]  
• Hoymans, V. Y., Bosmans, J. M., Ursi, D., Martinet, W., Wuyts, F. L., Van Marck, E., Altwegg, M., Vrints, C. J., Ieven, M. M. (2004). Immunohistostaining Assays for Detection of Chlamydia pneumoniae in Atherosclerotic Arteries Indicate Cross-Reactions with Nonchlamydial Plaque Constituents. J. Clin. Microbiol. 42: 3219-3224 [Abstract] [Full Text]  
• Apfalter, P., Hammerschlag, M. R., Boman, J., Wojta, J., Huber, K., Huk, I. (2003). Reliability of Nested PCR for the Detection of Chlamydia pneumoniae in Carotid Artery Atherosclerosis. Stroke 34 : e73-e75 [Full Text]